MOLPROBITY STRUCTURE VALIDATION PROGRAMS : MOLPROBITY (KING, REDUCE, AND PROBE) AUTHORS : I.W. ...MOLPROBITY STRUCTURE VALIDATION PROGRAMS : MOLPROBITY (KING, REDUCE, AND PROBE) AUTHORS : I.W.DAVIS,J.M.WORD URL : HTTP://KINEMAGE.BIOCHEM.DUKE.EDU/MOLPROBITY/ AUTHORS : J.S.RICHARDSON,W.B.ARENDALL,D.C.RICHARDSON REFERENCE : NEW TOOLS AND DATA FOR IMPROVING : STRUCTURES, USING ALL-ATOM CONTACTS : METHODS IN ENZYMOLOGY. 2003;374:385-412. MOLPROBITY OUTPUT SCORES: ALL-ATOM CLASHSCORE : 6.42 (4.23 B<40) LPXA (PROTEIN CHAIN) BAD ROTAMERS : 0.5% 1/204 (TARGET 0-1%) RAMACHANDRAN OUTLIERS : 0.0% 0/260 (TARGET 0.2%) RAMACHANDRAN FAVORED : 97.7% 254/260 (TARGET 98.0%) PEPTIDE 920 (PEPTIDE INHIBITOR OF LPXA) BAD ROTAMERS : 0.0% 0/9 (TARGET 0-1%) RAMACHANDRAN OUTLIERS : 0.0% 0/10 (TARGET 0.2%) RAMACHANDRAN FAVORED :100.0% 10/10 (TARGET 98.0%)
Remark 300
BIOMOLECULE: 1 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT WHICH CONSISTS OF 2 CHAIN(S) ...BIOMOLECULE: 1 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT WHICH CONSISTS OF 2 CHAIN(S). THERE IS ONE COPY OF THE LPXA MONOMER BOUND TO ONE INHIBITORY PEPTIDE PER ASYMMETRIC UNIT. THE BIOLOGICALLY ACTIVE LPXA MOLECULE, WHICH IS A HOMO-TRIMER, SITS ON A CRYSTALLOGRAPHIC THREE-FOLD AXIS. SWITCHING THE INDEX OF THE LPXA-PEPTIDE COMPLEX FROM THE CUBIC P2(1)3 TO THE ORTHORHOMBIC P2(1)2(1)2(1), WHICH IS THE MAXIMAL NON-ISOMORPHIC SUBGROUP LACKING THE THREE-FOLD AXIS, RESULTS IN A TRIPLING OF MOLECULES IN THE ASYMMETRIC UNIT, AND THE FORMATION OF THE BIOLOGICALLY ACTIVE TRIMER.